158 related articles for article (PubMed ID: 12581694)
1. Developmental immunotoxicity testing: a review.
Holsapple MP
Toxicology; 2003 Apr; 185(3):193-203. PubMed ID: 12581694
[TBL] [Abstract][Full Text] [Related]
2. Developmental immunotoxicology and risk assessment: a workshop summary.
Holsapple MP
Hum Exp Toxicol; 2002; 21(9-10):473-8. PubMed ID: 12458903
[TBL] [Abstract][Full Text] [Related]
3. Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary.
Boverhof DR; Ladics G; Luebke B; Botham J; Corsini E; Evans E; Germolec D; Holsapple M; Loveless SE; Lu H; van der Laan JW; White KL; Yang Y
Regul Toxicol Pharmacol; 2014 Feb; 68(1):96-107. PubMed ID: 24280359
[TBL] [Abstract][Full Text] [Related]
4. Summary of a workshop on nonclinical and clinical immunotoxicity assessment of immunomodulatory drugs.
Piccotti JR; Lebrec HN; Evans E; Herzyk DJ; Hastings KL; Burns-Naas LA; Gourley IS; Wierda D; Kawabata TT
J Immunotoxicol; 2009 Mar; 6(1):1-10. PubMed ID: 19519157
[TBL] [Abstract][Full Text] [Related]
5. Immunotoxicogenomics: the potential of genomics technology in the immunotoxicity risk assessment process.
Luebke RW; Holsapple MP; Ladics GS; Luster MI; Selgrade M; Smialowicz RJ; Woolhiser MR; Germolec DR
Toxicol Sci; 2006 Nov; 94(1):22-7. PubMed ID: 16882865
[TBL] [Abstract][Full Text] [Related]
6. Juvenile immunotoxicology.
Holsapple MP; O'Lone R
Toxicol Pathol; 2012; 40(2):248-54. PubMed ID: 22252913
[TBL] [Abstract][Full Text] [Related]
7. Development immunotoxicology and risk assessment. Conclusions and future directions: a personal view from the session chair.
Dayan AD
Hum Exp Toxicol; 2002; 21(9-10):569-72. PubMed ID: 12458915
[TBL] [Abstract][Full Text] [Related]
8. The mouse as a model for developmental immunotoxicology.
Holladay SD; Blaylock BL
Hum Exp Toxicol; 2002; 21(9-10):525-31. PubMed ID: 12458911
[TBL] [Abstract][Full Text] [Related]
9. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
Kavlock R; Dix D
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
[TBL] [Abstract][Full Text] [Related]
10. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
[TBL] [Abstract][Full Text] [Related]
11. Investigative Immunotoxicology.
Anderson SE; Shane HL
Methods Mol Biol; 2018; 1803():27-46. PubMed ID: 29882131
[TBL] [Abstract][Full Text] [Related]
12. Developmental immunotoxicity (DIT) testing of pharmaceuticals: current practices, state of the science, knowledge gaps, and recommendations.
Collinge M; Burns-Naas LA; Chellman GJ; Kawabata TT; Komocsar WJ; Piccotti JR; Shenton J; Wierda D
J Immunotoxicol; 2012; 9(2):210-30. PubMed ID: 22428536
[TBL] [Abstract][Full Text] [Related]
13. Present and future of in vitro immunotoxicology in drug development.
Galbiati V; Mitjans M; Corsini E
J Immunotoxicol; 2010; 7(4):255-67. PubMed ID: 20735150
[TBL] [Abstract][Full Text] [Related]
14. Recent developments in regulatory requirements for developmental toxicology.
Kimmel CA; Makris SL
Toxicol Lett; 2001 Mar; 120(1-3):73-82. PubMed ID: 11323164
[TBL] [Abstract][Full Text] [Related]
15. Prospects for developmental immunotoxicity guidance and an update on ICH S8.
Hastings KL
J Immunotoxicol; 2005 Oct; 2(4):217-20. PubMed ID: 18958677
[TBL] [Abstract][Full Text] [Related]
16. Reproductive/developmental toxicity and immunotoxicity assessment in the nonhuman primate model.
Buse E; Habermann G; Osterburg I; Korte R; Weinbauer GF
Toxicology; 2003 Apr; 185(3):221-7. PubMed ID: 12581697
[TBL] [Abstract][Full Text] [Related]
17. Developmental Immunotoxicology and Risk Assessment. Proceedings of a workshop. 12-13 June 2001, Washington, DC, USA.
Hum Exp Toxicol; 2002; 21(9-10):469-572. PubMed ID: 12458902
[No Abstract] [Full Text] [Related]
18. Regulatory aspects of immunotoxicology.
Schulte A; Ruehl-Fehlert C
Exp Toxicol Pathol; 2006 Jul; 57(5-6):385-9. PubMed ID: 16713214
[TBL] [Abstract][Full Text] [Related]
19. Immunotoxicology: challenges in the 21st century and in vitro opportunities.
Hartung T; Corsini E
ALTEX; 2013; 30(4):411-26. PubMed ID: 24173166
[TBL] [Abstract][Full Text] [Related]
20. The use of the rat in developmental immunotoxicology studies.
Chapin RE
Hum Exp Toxicol; 2002; 21(9-10):521-3. PubMed ID: 12458910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
